Login / Signup

A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma.

Asao HiroseHideo KohMika NakamaeYasuhiro NakashimaMitsutaka NishimotoHiroshi OkamuraYosuke MakuuchiMasatomo KunoTeruhito TakakuwaKentaro IdoKazuki SakatokuMasayuki HinoHirohisa Nakamae
Published in: Bone marrow transplantation (2024)
Keyphrases
  • diffuse large b cell lymphoma
  • acute myeloid leukemia
  • low dose
  • high dose
  • bone marrow
  • cell therapy
  • mesenchymal stem cells